Total Raised

$5M

Investors Count

4

Funding, Valuation & Revenue

4 Fundings

Neurolief has raised $5M over 4 rounds.

Neurolief's latest funding round was a Convertible Note for $5M on August 21, 2025.

Date

Round

Amount

Investors

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Revenue

Sources

8/21/2025

Convertible Note

$5M

$XXM

0

FY undefined

3

12/28/2023

Corporate Minority

$XXM

0

FY undefined

10

1/1/2017

Series A

$XXM

0

FY undefined

0

1/1/2015

Seed VC

$XXM

0

FY undefined

10

Date

8/21/2025

12/28/2023

1/1/2017

1/1/2015

Round

Convertible Note

Corporate Minority

Series A

Seed VC

Amount

$5M

Investors

Valuation

$XXM

$XXM

$XXM

$XXM

Revenue

0

FY undefined

0

FY undefined

0

FY undefined

0

FY undefined

Sources

3

10

0

10

Start free trial
New call-to-action

Neurolief Investors

4 Investors

Neurolief has 4 investors. Brainsway invested in Neurolief's Convertible Note funding round.

First funding

Last Funding

Investor

Rounds

Board Seats

Type

Location

8/21/2025

8/21/2025

1
Convertible Note

Corporation

Israel

00/00/0000

00/00/0000

Sawai Group Holdings

Subscribe to see more

Holding Company

Japan

00/00/0000

00/00/0000

Champel Capital

Subscribe to see more

Venture Capital

Israel

00/00/0000

00/00/0000

Terra Venture Partners

Subscribe to see more

Venture Capital

Israel

First funding

8/21/2025

00/00/0000

00/00/0000

00/00/0000

Last Funding

8/21/2025

00/00/0000

00/00/0000

00/00/0000

Investor

Sawai Group Holdings

Champel Capital

Terra Venture Partners

Rounds

1
Convertible Note

Subscribe to see more

Subscribe to see more

Subscribe to see more

Board Seats

Type

Corporation

Holding Company

Venture Capital

Venture Capital

Location

Israel

Japan

Israel

Israel

New call-to-action

Compare Neurolief to Competitors

Salvia BioElectronics Logo
Salvia BioElectronics

Salvia BioElectronics is a clinical-stage medical device company focused on developing neuromodulation therapy for chronic migraine relief. The company offers a bioelectronic implant designed to target key nerves involved in migraine. Salvia BioElectronics is advancing clinical development for its migraine therapy and exploring applications for cluster headache treatment. It was founded in 2017 and is based in Eindhoven, Netherlands.

N
Nu Eyne

Nu Eyne operates as a medical research and development (R&D) company focused on electroceuticals within the healthcare sector. The company develops devices that utilize neuromodulation technology to address conditions like dry eye syndrome. It was founded in 2017 and is based in Seoul, South Korea.

B
BMDSys

BMDSys develops, produces, sells and services non-invasive, contact-free cardiac diagnostic imaging systems using extremely high sensitive magnetic sensors. It does not expose the patient to any X-Rays, magnetic field or any other kind

P
PetsDx Imaging

PetsDx Veterinary Imaging, Inc. is engaged in veterinary medicine and magnetic resonance imaging (MRI). PetsDX works with local veterinarians.

L
Leptos BioMedical

Leptos BioMedical is a company that operates in the online gaming and gambling industry, focusing on providing a variety of online slot games. The company offers a range of gaming services including high RTP (Return to Player) slots, progressive jackpots, and features such as free spins, catering to users interested in real money gaming. In addition to slots, Leptos BioMedical provides live casino games, sports betting, fishing games, lottery services, and poker rooms. It was founded in 2002 and is based in Fridley, Minnesota.

B
Bramhansh

Bramhansh is a health tech company that focuses on the field of neurostimulation within the medtech industry. The company offers a patented, clinically validated wearable device for migraine relief, as well as non-invasive solutions for stress and sleep disorders. It was founded in 2018 and is based in Bangalore, India.

Loading...

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.